{"disease":{"id":"schwannomas","name":"schwannomas"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07364955","title":"Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Albert Torrents Torrero","has_results":false},{"nct_id":"NCT05684692","title":"Screening Trial for Pain Relief in Schwannomatosis (STARFISH)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03542773","title":"Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT01767792","title":"Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":true},{"nct_id":"NCT06322342","title":"Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Reveal Pharmaceuticals Inc.","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}